Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by yorgosGKon Apr 16, 2018 4:45pm
377 Views
Post# 27893565

Someone wants this low, but only for the time being

Someone wants this low, but only for the time being

THIS IS ALL IN MY OPINION - NO CONCRETE EVIDENCE, PURELY SPECULATION OF WHAT I THINK IS HAPPENING......

Someone wants this low to cash in after this week. It's in someones interest....Look at the filtered sell trades below....Oh and by the way - 018 broker ID is Echelon Wealth (the guys about to get their hands on warrants @.13 and debentures).

Today's trades from 018 (notice the filter date - no sell trades came before April 10th 2018, the start of our decline). 

**right click and open in a new tab to zoom in**
User image

In my opinion (and if Echelon was smart) - all things point to getting shorted out soon at a low level , to skyrocket (coincidently in time for the 21st). I'm here for the ride - top up people. Not going to get into this more because its speculation and not fair to point fingers without concrete evidence, but I hope people can put 2 and 2 together and play it how they want.

We all know KALY is a winner no matter what. This noise has to be put to sleep though. Will be an interesting next 2 weeks to say the least. Stay for the ride; your probobly going to want to. Cheers. 

 

Bullboard Posts